Product
mRNA-1010.4
2 clinical trials
2 indications
Indication
COVID-19Indication
InfluenzaClinical trial
A Phase 1/2, Randomized, Observer-blind, Active-Control Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-based Influenza and SARS-CoV-2 Multi-component Vaccines in Healthy AdultsStatus: Active (not recruiting), Estimated PCD: 2024-11-29
Clinical trial
A Phase 2, Randomized, Active-Controlled, Observer-Blind, Dose-Ranging Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA Vaccine Candidate Variations in Healthy Adults 18 to 49 Years of AgeStatus: Completed, Estimated PCD: 2023-12-19